From Surf Wiki (app.surf) — the open knowledge base

Pridefine

Chemical compound

| elimination_half-life =

Pridefine (AHR-1,118) is a drug which was investigated as an antidepressant in the late 1970s and early 1980s, but was never marketed. It acts as a balanced reuptake inhibitor of serotonin, dopamine, and norepinephrine, and also has some weak releasing activity.

In clinical trials pridefine was found to be as efficacious as the tricyclic antidepressants amitriptyline and imipramine in the treatment of major depressive disorder but was much more tolerable in comparison and also had an earlier onset of action. It has been shown to be effective in the treatment of alcoholism as well.

References

(1980). "Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain". [[Biochemical Pharmacology (journal).
(1980). "Open trial evaluation of a pyrrolidine derivative (AHR-1118) on norepinephrine metabolism". [[Progress in Neuro-Psychopharmacology]].
(1981). "Noncompetitive amine uptake inhibition by the new antidepressant pridefine". [[Journal of Neurochemistry]].

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

antidepressants pyrrolidines serotonin–norepinephrine–dopamine-reuptake-inhibitors serotonin-norepinephrine-dopamine-releasing-agents

Want to explore this topic further?

Ask Mako anything about Pridefine — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report